Since then, he has focused on patient recruitment and overall ... In the industry, about 75% to 80% of all research studies are not completed on time, delaying important medical treatments for those ...

Explore the evolving landscape of clinical trials in drug discovery and learn about recent breakthroughs transforming the ...

“Aggregated quality of life data across three robust clinical trials suggests ... late-phase studies, most patients (≥91% in ATLAS, ≥94% in ENVISION) completed the questionnaires at baseline ...

A Phase I trial involving ten patients with relapsed or refractory classical Hodgkin lymphoma or T-cell lymphoma has achieved a 100% overall response rate and a 50% complete remission rate, in ...

Researchers from the Sant Pau Research Institute (IR Sant Pau), in collaboration with Sant Pau Hospital and the Josep ...

Patient recruitment remains a significant challenge for biopharma companies, often leading to delays and increased costs in clinical trials ... pre-screening tasks to complete before moving ...

This not only points to financial misconduct, but also raises suspicion that the companies wanted to get the trials completed ... number of patients continued to decline, illegal clinical trials ...

and ongoing communication with patients and caregivers to answer any questions that arise. 3. Optimise clinical research stipend management: Expedite completed visit confirmation and extend timely ...

Completed SAD/MAD dosing in KT-621 ... that it recently initiated dosing in its BroADen Phase 1b clinical trial evaluating KT-621, an oral, highly selective, potent degrader of STAT6, in patients with ...

Renibus Therapeutics has completed ... III PROTECT trial, assessing RBT-1 (stannic protoporfin/iron sucrose) in minimising post-operative complication risk in cardiac surgery patients.